North Point Portfolio Managers Corp OH Sells 297 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

North Point Portfolio Managers Corp OH lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,841 shares of the healthcare conglomerate’s stock after selling 297 shares during the period. UnitedHealth Group accounts for 2.3% of North Point Portfolio Managers Corp OH’s portfolio, making the stock its 21st largest position. North Point Portfolio Managers Corp OH’s holdings in UnitedHealth Group were worth $13,160,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of UNH. Bell Investment Advisors Inc boosted its stake in UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after acquiring an additional 24 shares during the last quarter. Harbor Investment Advisory LLC increased its holdings in UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares during the last quarter. Austin Private Wealth LLC boosted its holdings in UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after buying an additional 111 shares during the last quarter. Vanguard Personalized Indexing Management LLC increased its stake in shares of UnitedHealth Group by 7.9% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock valued at $39,802,000 after acquiring an additional 5,537 shares during the last quarter. Finally, Capital Insight Partners LLC grew its holdings in UnitedHealth Group by 3.8% during the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on UNH shares. HSBC raised their price objective on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Truist Financial lifted their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Stock Down 0.2 %

Shares of UnitedHealth Group stock traded down $1.43 on Friday, reaching $590.14. 2,944,699 shares of the company were exchanged, compared to its average volume of 4,101,315. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a 50-day moving average of $546.21 and a 200 day moving average of $511.95. The company has a market capitalization of $544.95 billion, a price-to-earnings ratio of 36.07, a PEG ratio of 1.63 and a beta of 0.59. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $593.26.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the business earned $6.14 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.